ACERAGEN, INC. NONQUALIFIED STOCK OPTION GRANT AGREEMENT GRANTED PURSUANT TO THE 2022 EQUITY INCENTIVE PLANNonqualified Stock Option Grant Agreement • April 13th, 2023 • Aceragen, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledApril 13th, 2023 Company Industry JurisdictionThis NONQUALIFIED STOCK OPTION GRANT AGREEMENT (the “Agreement”), dated as of [●] (the “Date of Grant”), is delivered by Aceragen, Inc. (formerly known as Idera Pharmaceuticals, Inc.) (the “Company”) to [●] (the “Participant”).
ACERAGEN, INC. NONQUALIFIED STOCK OPTION GRANT AGREEMENT GRANTED PURSUANT TO THE 2022 EQUITY INCENTIVE PLAN FOR DIRECTORS OF THE COMPANYNonqualified Stock Option Grant Agreement • April 13th, 2023 • Aceragen, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledApril 13th, 2023 Company Industry JurisdictionThis NONQUALIFIED STOCK OPTION GRANT AGREEMENT (the “Agreement”), dated as of [●] (the “Date of Grant”), is delivered by Aceragen, Inc. (formerly known as Idera Pharmaceuticals, Inc.) (the “Company”) to [●] (the “Participant”).